En Es
Categories

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including clinical chemistry and immunoassay analyzers and hematology solutions. The company’s offerings are ideal for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics.
Gold member
Products Covid-19Summary
Close

Covid-19 Abbott Diagnostics

Clinical Laboratory

COVID-19 Antigen Test
BinaxNOW COVID-19 Ag Card

The BinaxNOW COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA), offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19. The BinaxNOW test can be displayed on Abbott’s new optional app - available at no charge - for iPhone and Android devices called NAVICA. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
More details

SARS-CoV-2 Antibody Test
AdviseDx SARS-CoV-2 IgM Assay

The AdviseDx SARS-CoV-2 IgM assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, serum separator tube and plasma (dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium heparin). The assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection and should not be used to diagnose acute SARS-CoV-2 infection.
More details

SARS-CoV-2 Antibody Test
SARS-CoV-2 IgG Assay

The SARS-CoV-2 IgG assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tube and plasma (ACD, CPD, CPDA-1, dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium citrate, sodium heparin). The assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection and should not be used to diagnose acute SARS-CoV-2 infection.
More details

COVID-19 Antigen Test
Panbio COVID-19 Ag Rapid Test Device

The Panbio COVID-19 Ag Rapid Test Device is intended for patients suspected of current COVID-19 infection and identifies potentially contagious patients in 15 minutes. Using patient-friendly nasal or nasopharyngeal sample collection types, the high performance rapid test enables immediate treatment or isolation measures to minimize transmission.
More details

COVID-19 Anitibody Test
Panbio COVID-19 IgG/IgM Rapid Test Device

The Panbio COVID-19 IgG/IgM Rapid Test Device is an in vitro diagnostic rapid test for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human serum, plasma, venous and fingerstick whole blood. The test provides preliminary test results within 10-20 minutes and is not intended to be used as a donor screening test for SARS-CoV-2.
More details

SARS-CoV-2 Antibody Test
Panbio SARS-CoV-2 IgG ELISA

The Panbio SARS-CoV-2 IgG ELISA is an antibody test that helps identify individuals with immune response to SARS-CoV-2 and enables greater access for broad population surveillance. The test is compatible with manual ELISA, and is adaptable to semi-automated and fully-automated equipment, enabling easy deployment within a lab's existing infrastructure.
More details

SARS-CoV-2 Assay
Alinity m SARS-CoV-2 Assay

The Alinity m SARS-CoV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs collected by a healthcare provider, from patients who are suspected of COVID-19 infection. The assay runs on the Alinity m system having a simple workflow with primary sample tube loading to provide operational efficiencies to curb the increasing testing volume with the existing lab staff.
More details

SARS-CoV-2 Assay
Abbott RealTime SARS-CoV-2 Assay

The Abbott RealTime SARS-COV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider. Engineered with dual target assay for RdRp and N-genes, it provides a fully automated solution to help laboratories address the urgent need for patient testing during the Coronavirus (COVID-19) pandemic.
More details

Sample Preparation System
m24sp

The m24sp is an instrument for laboratories with mid-throughput requirements that offers automated flexibility. An automated bench-top system with a small footprint, the m24sp features reliable extraction using mSample Preparation chemistry and variable extraction with ready-to-use and re-usable reagents plus flexible batch size.
More details

Molecular Diagnostics Analyzer
ALINITY m

The ALINITY m is a fully integrated and automated molecular diagnostics analyzer that uses innovative technology to deliver the next level of flexibility and efficiency to the lab. With its Readiflex technology, 20 onboard assay capacity and broad assay menu, the allows consolidation of 60% of routine PCR testing on one instrument.
More details
Close

About Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including clinical chemistry and immunoassay analyzers and hematology solutions. The company’s offerings are ideal for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 Assay

SARS-CoV-2 Assay

Model: Abbott RealTime SARS-CoV-2 Assay
Request Information

Description:

The Abbott RealTime SARS-COV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider.
Read More

Full Description

Description

The Abbott RealTime SARS-COV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider. Engineered with dual target assay for RdRp and N-genes, it provides a fully automated solution to help laboratories address the urgent need for patient testing during the Coronavirus (COVID-19) pandemic. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Abbott Diagnostics (SARS-CoV-2 Assay)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions